Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition and Sensory-Prefrontal-cortex-Amygdala (SPA) Pathology in Posttraumatic Stress Disorder (PTSD) (Aims 1 & 2; Expts. 1a &1b)

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arousal and hypervigilance, with the goal of assessing tACS brain stimulation technology as a novel intervention for symptoms of anxiety.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:

• Right-handed

• With normal or corrected-to-normal vision and normal olfaction

• Between the ages of 18 and 50 years

• Meeting the tACS screening criteria (see List I below; e.g., lack of a serious head injury or loss of consciousness)

• Patients: Diagnosis of PTSD

• Patients: If taking psychotropic medications, medication stability in the past 2 months

• If having mild substance use disorder (for patients) or occasional substance use, abstention from use 48 hours before the experiment.

Locations
United States
Texas
The University of Texas Health Science Center at Houston
RECRUITING
Houston
Contact Information
Primary
Wen Li, PhD
Wen.Li.1@uth.tmc.edu
(713) 486-2700
Backup
Jada Malveaux, MA
Jada.Malveaux@uth.tmc.edu
(713) 486-2700
Time Frame
Start Date: 2022-04-05
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 160
Treatments
Experimental: Transcranial Alternating Current Stimulation (tACS)
Sham_comparator: Sham for Transcranial Alternating Current Stimulation (tACS)
Active_comparator: Active Control - Transcranial Random Noise stimulation (tRNS)
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Mental Health (NIMH)
Leads: The University of Texas Health Science Center, Houston

This content was sourced from clinicaltrials.gov